About   Help   FAQ
Tg(VIPR2/Hspa1b-cre/ERT2)20Dlee
Transgene Detail
Summary
Symbol: Tg(VIPR2/Hspa1b-cre/ERT2)20Dlee
Name: transgene insertion 20, Daekee Lee
MGI ID: MGI:6727074
Synonyms: VIPR2-ERT2CreERT2-020
Transgene: Tg(VIPR2/Hspa1b-cre/ERT2)20Dlee  Location: unknown  
Alliance: Tg(VIPR2/Hspa1b-cre/ERT2)20Dlee page
Transgene
origin
Strain of Origin:  FVB/N
Transgene
description
Transgene Type:    Transgenic (Inducible, Recombinase)
Inducer:    tamoxifen
Mutation:    Insertion
 
Tg(VIPR2/Hspa1b-cre/ERT2)20Dlee expression driven by 1 gene
 
Mutation details: A transgene consisting of hs1753 (chr7:158,888,320-158,891,362) enhancer element located in intron 4 of human VIPR2 gene subcloned into Hsp68 promoter fused with ERT2CreERT2-pA to drive expression of cre in response to tamoxifen in developing heart. A total of nine transgenic founders lines 1, 17, 20, 22, 23, 29, 30, 32, 33 were obtained. All transgenic lines showed heart-specific cre activity when bred to a cre reporter mouse. (J:297289)
Recombinase
activity
Activity:
 Tissue activity of this recombinase allele
Driver: VIPR2 (human)
Summary of all recombinase alleles driven by VIPR2.
 

Find Mice (IMSR)
Mouse strains and cell lines available from the International Mouse Strain Resource (IMSR)
Carrying this Mutation:  Mouse Strains: 0 strains available      Cell Lines: 0 lines available
References
Original:  J:297289 Chin HJ, et al., Tamoxifen-inducible cardiac-specific Cre transgenic mouse using VIPR2 intron. Lab Anim Res. 2020;36:31
All:  1 reference(s)
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/19/2024
MGI 6.24 		The Jackson Laboratory